MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics 
StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / May 17, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare...
Moderna Announces Advancements in mRNA Platform Science for Application Across Multiple Diseases at Science and Technology Day
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a...
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 – Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application
SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the...
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
ORLANDO, FL / ACCESSWIRE / May 17, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter...
H1 and Lightship Partner to Accelerate Clinical Studies with Diversity, Equity, and Inclusion Data
Leveraging H1’s Trial Landscape solution, Lightship will incorporate important diversity data into its clinical trials process, bringing life-changing therapies to...
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
New strains to provide crucial insights in mental health research across the sector Optimi Health Functional Mushrooms Optimi Health Lion's...
Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)
FDA granted IND clearance for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic...
Icario/Harris Poll Survey Uncovers Challenges Associated with Educating Medicaid Members on Redetermination and Re-enrollment
Findings Reaffirm Significant Disparities Between Higher-and Lower-Income Members, While Only 56% of Members Report Receiving Helpful Info About Medicaid Redetermination...
Virax Biolabs Introduces New Board of Directors, Announces Members
London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Introduces New Board of Directors, Announces Members London, United...
New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy
Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE)...
Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022
MIAMI, May 17, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for...
Trusting Heart Blood Center’s Documentary, “The Platelet Problem,” is Recognized in the Top Ten at the 26th Annual Webby Awards
Webby Award Trusting Heart Blood Center’s Webby Award for their microdocumentary, ‘The Platelet Problem,’ placing in the top 10 Best...
Assure to Attend Investor Conferences in May and June 2022
DENVER, May 17, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
CUPERTINO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage...
BioCorRx Business Update for the First Quarter of 2022
ANAHEIM, CA, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
WIMI Hologram Academy: Research on the boundary between Virtuality and Reality in the application scene based on VR technology
HONG KONG, May 17, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
Evoke Pharma to Present at H.C. Wainwright Global Investment Conference
SOLANA BEACH, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily...
Organovo Achieves 3D Tissue Model for Crohn’s Disease
SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional (3D) biology company focused on...
Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC
– Enrollment Stopped Early for Efficacy –EXTON, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” “we,” and...
Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer
Dr. Dhandayudham Brings Significant Frontline Addiction and Mental Health Medical Leadership Experience to AwaknToronto, Ontario--(Newsfile Corp. - May 17, 2022)...